Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MORPHIC HOLDING, INC.

(MORF)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 10/22 01:26:39 pm
57.895 USD   +0.46%
10/18INSIDER SELL : Morphic Holding
MT
10/12MORPHIC : to Participate in Jefferies IBD Therapeutics Summit
GL
09/01MORPHIC : Therapeutic Announces Participation in September Investor Conferences
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
53.44(c) 54.07(c) 57.16(c) 57.63(c) 57.15 Last
187 991 219 932 147 666 125 541 29 431 Volume
-9.04% +1.18% +5.71% +0.82% -0.83% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 26,7 M - -
Net income 2021 -97,6 M - -
Net Debt 2021 - - -
P/E ratio 2021 -21,1x
Yield 2021 -
Sales 2022 25,3 M - -
Net income 2022 -126 M - -
Net Debt 2022 - - -
P/E ratio 2022 -17,2x
Yield 2022 -
Capitalization 2 101 M 2 101 M -
Capi. / Sales 2021 78,8x
Capi. / Sales 2022 83,2x
Nbr of Employees 96
Free-Float 66,5%
More Financials
Company
Morphic Holding, Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing a pipeline of potentially first-in-class oral small molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. The Company is... 
Sector
Pharmaceuticals
Calendar
11/16Earnings Release
More about the company
Ratings of Morphic Holding, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about MORPHIC HOLDING, INC.
10/18INSIDER SELL : Morphic Holding
MT
10/12MORPHIC : to Participate in Jefferies IBD Therapeutics Summit
GL
09/01MORPHIC : Therapeutic Announces Participation in September Investor Conferences
AQ
08/30Certain Restricted Stock Units of Morphic Holding, Inc. are subject to a Lock-Up Agreem..
CI
08/30Certain Options of Morphic Holding, Inc. are subject to a Lock-Up Agreement Ending on 3..
CI
08/30Certain Common Stock of Morphic Holding, Inc. are subject to a Lock-Up Agreement Ending..
CI
08/23MORPHIC : Therapeutic Announces Appointment of Nisha Nanda, Ph.D., to Board of Directors (..
PU
08/23MORPHIC HOLDING, INC. : Change in Directors or Principal Officers, Other Events, Financial..
AQ
08/23Morphic Holding, Inc. Appoints Nisha Nanda to the Board of Directors
CI
08/23MORPHIC : Therapeutic Announces Appointment of Nisha Nanda, Ph.D., to Board of Directors
AQ
08/04MORPHIC : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
08/04MORPHIC : Announces Corporate Highlights and Second Quarter 2021 Financial Results (Form 8..
PU
08/04MORPHIC HOLDING, INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
08/04MORPHIC : Announces Corporate Highlights and Second Quarter 2021 Financial Results
AQ
08/04Morphic Holding, Inc. Appoints Susannah Gray to Its Board of Directors and the Audit Co..
CI
More news
News in other languages on MORPHIC HOLDING, INC.

- No features available -

More news
Analyst Recommendations on MORPHIC HOLDING, INC.
More recommendations
Chart MORPHIC HOLDING, INC.
Duration : Period :
Morphic Holding, Inc. Technical Analysis Chart | MORF | US61775R1059 | MarketScreener
Technical analysis trends MORPHIC HOLDING, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 57,63 $
Average target price 100,50 $
Spread / Average Target 74,4%
EPS Revisions
Managers and Directors
Praveen P. Tipirneni President, Chief Executive Officer & Director
Marc Schegerin Chief Operating & Financial Officer
Gustav A. Christensen Chairman
Bruce N. Rogers Chief Scientific Officer
Peter G. Linde Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
MORPHIC HOLDING, INC.71.77%2 101
JOHNSON & JOHNSON3.83%430 148
ROCHE HOLDING AG15.79%339 425
PFIZER, INC.16.27%240 303
NOVO NORDISK A/S56.55%239 079
ELI LILLY AND COMPANY42.84%218 640